MPN

News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
June, 2025
June 2025
M T W T F S S
 1
2345678
9101112131415
16171819202122
23242526272829
30  

MPN
May 18, 2025, 12:23 | Science
Naveen Pemmaraju: The Evolving Landscape of Epigenetic Target Molecules and Therapies in Myeloid Cancers
Naveen Pemmaraju, Professor and Director of BPDCN Program at the Department of Leukemia at the…
May 16, 2025, 07:27 | Blog
Ruben Mesa: New Patient Resource for Tracking MPN Shared at EuroNet MPN Meeting
Ruben Mesa, President and Executive Director of Atrium Health Levine Cancer Institute and Atrium Health…
May 4, 2025, 17:38 | Insight
Naveen Pemmaraju joined expert panel on myeloproliferative neoplasms at the Think Tank25 Meeting
Naveen Pemmaraju, Professor and Director of BPDCN Program at the Department of Leukemia at the…
Mar 19, 2025, 17:38 | Blog
Naveen Pemmaraju: An important evening of filming to help raise awareness in MPN clinical research
Naveen Pemmaraju, Professor and Director of the BPDCN Program at the Department of Leukemia at…
Jan 25, 2025, 12:41 | Societies
The faculty of  ESH CML MPN 2025 - European School of Haematology
European School of Haematology (ESH) shared a post on LinkedIn: "Meet the faculty of  ESH…
Dec 9, 2024, 15:53 | Blog
Highlights from ASH Annual Meeting 2024 by Naveen Pemmaraju
The 66th ASH Annual Meeting (ASH24) is taking place from December 7-10, 2024, in San…
Dec 8, 2024, 06:21 | Insight
Understanding and treating myelofibrosis
Nico Gagelmann shared a post on X: "Understanding and treating myelofibrosis A short thread on…
Sep 21, 2024, 14:48 | Career
Naveen Pemmaraju receives the IACH 2024 Special Achievement Award
The 7th Annual Meeting of the International Academy for Clinical Hematology (IACH), featuring the COMydAL,…
Sep 13, 2024, 23:49 | Blog
Naveen Pemmaraju: Wonderful to attend the highly successful SOHO2024 meeting
Naveen Pemmaraju posted the following on LinkedIn: “Wonderful to attend the highly successful SOHO2024 meeting held…
Aug 27, 2024, 23:05 | Societies
Stephen Oh: Grateful for the opportunity to share our latest research at MPN Workshop NC24
Stephen Oh, Co-Chief in Division of Hematology at Washington University School of Medicine, posted on X:…
Aug 27, 2024, 21:59 | Blog
Hear about the translational aspects of Myeloproliferative neoplasms from Joseph Scandura - VJHemOnc
The Video Journal of Hematology and Hematological Oncology shared a post on X: "Earlier, we…
Aug 6, 2024, 10:11 | Blog
Save the date for ESHCMLMPN2025
European School of Haematology shared on X: "SAVE THE DATE FOR ESHCMLMPN2025: March 7-9, 2025!…
Aug 6, 2024, 07:59 | Blog
Registration for NCCN's Patient Webinar on myeloproliferative neoplams is open
National Comprehensive Cancer Network shared on LinkedIn: “Join us for the upcoming Patient Webinar on September…
Jul 30, 2024, 07:14 | Blog
Naveen Pemmaraju: Superb clinic and research teams working together in Team Pemm clinic
Naveen Pemmaraju shared a post on X: "Superb clinic and research teams working together in…
Jul 11, 2024, 13:21 | Blog
Key Take-home Messages from EHA and ASCO 2024 - IACH
IACH (International Academy for Clinical Hematology) shared a post on X: "Our latest IACH Post-Congress Webinars: …
Jul 8, 2024, 05:08 | Blog
Ruben Mesa: Join us for this clinically focused MPN workshop
Ruben Mesa shared a post by the European School of Haematology (ESH) on LinkedIn, adding:…
Jun 29, 2024, 16:24 | Insight
Anand Patel: Highlighting challenges in MPNs at SOHO 2024
Anand Patel, Assistant Professor and Director of the Inpatient Leukemia Service at the University of Chicago,…
Jun 25, 2024, 16:07 | Blog
Join IACH for the upcoming IACH Post EHA and ASCO webinar
The International Academy for Clinical Hematology shared on X/Twitter: "Join us for the upcoming IACH…
Jun 18, 2024, 10:27 | Insight
Naveen Pemmaraju: Our brand new MPN state-of-the-art review paper
Naveen Pemmaraju shared on LinkedIn:         . "Super excited to share our brand…
Jun 18, 2024, 02:57 | Blog
Skoda: clonal evolution of Myeloproliferative Neoplasms
Talha Badar, Assistant Professor at Mayo Clinic Comprehensive Cancer Center shared on X: “Skoda: clonal…
Jun 17, 2024, 07:05 | Societies
15 Posts You Should Not Miss From EHA 2024!
The European Hematology Association (EHA) Hybrid Congress or EHA2024 will took place in Madrid, Spain…
Jun 15, 2024, 12:41 | Blog
Naveen Pemmaraju: With MPN Guru and dear friend Prof Ruben Mesa at EHA2024
Naveen Pemmaraju recently shared a post on X: “Wonderful to be here at EHA2024 with MPN…
Jun 3, 2024, 23:56 | Insight
Naveen Pemmaraju: Wonderful discussion and exchange of ideas with Ruben Mesa and John Mascarhenas at ASCO24
Naveen Pemmaraju shared a post on LinkedIn: “A truly wonderful discussion and exchange of ideas on…
May 10, 2024, 11:47 | Blog
Andrew M. Evens: Thank you for the invite to the 1st HemeOnc Pulse LIVE
Andrew M. Evens, Deputy Director for Clinical Services at Rutgers Cancer Institute, recently shared on…
May 7, 2024, 14:57 | Blog
Naveen Pemmaraju: Honored to have served as Invited Expert Faculty at HemOnc Pulse
Naveen Pemmaraju shared on LinkedIn: "HOPLive24 HemOnc Pulse | Thanks Chadi Nahban and team for organizing…
Mar 31, 2024, 09:02 | Insight
Yu-Hung Wang: Loss of Dnmt3a increases self-renewal of JAK2V617F HSCs
Yu-Hung Wang, PhD student at The University of Manchester, shared on X/Twitter: “Loss of Dnmt3a…
Mar 26, 2024, 05:25 | Insight
Stephen Oh: The role of NFκB signaling effectors in MPN disease biology
Stephen Oh, Co-Chief in Division of Hematology at Washington University School of Medicine in St.…
Feb 3, 2024, 17:12 | Positive
Naveen Pemmaraju: Thank you to Jane Fonda for helping us raise so much awareness for research on behalf of our patients with MPNs
Naveen Pemmaraju shared on X/Twitter: "It was amazing to spend a few quality moments with…
Oct 4, 2023, 17:21 | Insight
Registration is open for this year’s EHASWG Scientific Meeting on MDS/MPN/AML- Kordasti Lab.
Quoting Kordasti Lab on X/Twitter: “Interested in MDS, MPN, or AML? Registration is open for…
Sep 10, 2023, 12:31 | Blog
David Steensma: Those of us Bob trained won't forget his influence.
David Steensma, renowned hematologist-oncologist and the CMO of Ajax Therapeutics, shared on X (Twitter), "I…
Sep 8, 2023, 16:13 | Societies
Naveen Pemmaraju: Delighted to be recognized by the Society of Hematologic Oncology for the Honorable Distinction Award
Naveen Pemmaraju, Leukemia Professor at the MD Anderson Cancer Center, shared on his Twitter account:…
All: 31 Posts: 1 - 100
Special Coverage